Montelukast vs Osimertinib

## Montelukast vs Osimertinib: Overview

This comparison examines the pharmacological differences between **Montelukast** and **Osimertinib**.

## Mechanism of Action

**Montelukast**: Selective leukotriene D4 receptor antagonist.

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Montelukast — 2.7-5.5 hours; Osimertinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Montelukast — C35H36ClNO3S; Osimertinib — C28H33N7O2.

**Molecular Weight**: Montelukast — 586.1800 g/mol; Osimertinib — 499.6050 g/mol.

**Type**: Montelukast — Small molecule; Osimertinib — Small molecule.